Clinical · Molecular biology
Spatial transcriptomics identifies tumor-intrinsic and stromal programs associated with immune exclusion in NSCLC
This study investigates the molecular and spatial mechanisms underlying CD8+ T-cell immune exclusion in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint blockade. Spatial CD8+ exclusion, defined by stroma-restricted T cells that fail to penetrate tumor nests, correlates with reduced objective response rates and shorter progression-free survival. Multi-omic integration—including GeoMx spatial transcriptomics, multiplex immunofluorescence, and bulk transcriptomics—revealed tumor-intrinsic defects in antigen-presentation machinery, specifically involving HLA class I genes and TAP1, along with uncoupled IFN-γ signaling. Concurrently, the excluded stroma is characterized by myofibroblastic cancer-associated fibroblasts and collagen-dense barriers, accompanied by CD8+ T cells displaying impaired metabolic activation and lower TCR diversity rather than classic exhaustion.